Universal Biosensors, Inc. announced Mr. Graham McLean has been appointed Chairman of the Board at UBI. Graham was appointed to the board of UBI in March 2022 and replaces Mr. Craig Coleman who will remain on the board as a Non-Executive Director. Mr. McLean is an experienced senior executive and has been a leader in the medical technology industry in Australia, Asia and USA for more than 20 years.

His most recent executive role was with Stryker Corporation as President Asia Pacific from 2017 to 2020 where he delivered significant sales growth. Over the last few years under Craig's Chairmanship, UBI have made significant changes to the way it conducts its business. UBI has upgraded the Senior Management Team led by the recruitment of John Sharman as CEO, clarified its business strategy, strengthened its capital settings and most importantly developed a pipeline of market leading products which all use UBI's proprietary biosensor intellectual property and manufacturing platform.

As UBI's products are progressively released during 2023, the opportunity and focus shifts to sales and revenue. Given Graham's experience in the global distribution of medical technology, Craig and the Board believes this is the right time to transition to him taking up the Chair.